Interdisciplinary GU Cancer Forum 2025 Combination Therapies in prostate cancer, active surveillance, GG1 prostate cancer, radical prostatectomy.

(UroToday.com) The 2025 ASCO annual meeting featured a prostate cancer oral abstract session and a presentation by Dr. Theodore DeWeese discussing a phase 3, randomized, placebo-controlled clinical ...

Interdisciplinary GU Cancer Forum 2025, prostate cancer, de novo high-volume metastatic hormone-sensitive prostate cancer (mHSPC), Advances in Immunotherapy for prostate cancer, 177Lu-PSMA radioligand ...

Interdisciplinary GU Cancer Forum 2025, Emerging Data and Advances in Prostate cancer Screening, Prostate cancer, homologous recombination repair (HRR), metastatic castration-resistant prostate cancer ...

Interdisciplinary GU Cancer Forum 2025, Prostate Cancer, Neoadjuvant Management of High-Risk Prostate Cancer, PROTEUS trial, GUNS trial, Genomic Umbrella Neoadjuvant Study, apalutamide, FOXA1 ...

Clear explanation of what a "Foley" or indwelling catheter is, the 2 types of insertions, their use cases, and the risk of CAUTI if catheterization isn't properly managed.

SNMMI 2025 novel PSMA-targeting drug 177Lu-P17-088, metastatic castration-resistant prostate cancer (mCRPC), VISION and PSMAfore trials, PCWG3 guidelines.

(UroToday.com) The 2025 SNMMI annual meeting featured a prostate cancer and dosimetry session and a presentation by Dr. Sabina Dizdarevic discussing eight-year follow-up of patient outcomes and bone ...

SNMMI annual meeting featured a clinical diagnosis and therapy session and a presentation by Dr. Kambiz Rahbar discussing the clinical value of the PROSTest to detect biochemical recurrence in ...

SNMMI annual meeting featured a clinical diagnosis and therapy session and a presentation by Dr. Kambiz Rahbar discussing the utility of the PROSTest to predict response to 177 Lu-PSMA therapy in ...

(UroToday.com) The 2025 SNMMI annual meeting featured a prostate cancer and dosimetry session and a presentation by Dr. Loic Djaileb discussing clinical protocols to monitor efficacy of 177 Lu-PSMA ...

Identifying cribriform and intraductal histology on magnetic resonance imaging-assisted biopsy for patients with intermediate-grade prostate cancer: Implications for active surveillance. July 7, 2025 ...